Unlucky Breaks Or Compliance Trend? BIMO Spotlight Falls On Orthopedics
This article was originally published in The Gray Sheet
Executive Summary
FDA has initiated disqualification proceedings against three orthopedic surgeons serving as clinical investigators in the last three months